STLN: Starling Oncology, Inc.
Performance
STLN +12.83%
Watchlist
Select an item
Summary
STLN at a glance
STLN returned +12.84% over the past year and -12.36% a year over five years. Its worst drop in that year was -48.65%, smaller than 25% of stocks on Redstone, and its Sharpe ratio of 0.59 beats 55% of stocks on Redstone. It pays no dividends.
Current Drawdown
-43.26%
Rolling Volatility
173.53%
Actions
Metrics
Risk Indicators
Alpha39.73%
Beta1.55x
Sharpe0.59
Sortino0.85
Omega1.12
Calmar0.26
Martin2.90
Profile
About STLN
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.
- Sector
- Health Care
- Industry
- Services: Offices & Clinics of Doctors of Medicine
- Market cap
- $408M
- Listed
- Nov 2021
- Employees
- 641
- Headquarters
- Cerritos, CA
- Website
- starlingoncology.com
Comparisons